MarginsXMarginsX
Home › Markets › Health Care › ARDX

Ardelyx Inc. (ARDX)

ARDX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$3.07
-0.65% on the day
Market cap
$771.7M
Small cap
Revenue · 2025
$407.3M
+22.1% on 2024
Net income · 2025
-$61.6M
-15.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1437402/000143740226000013/0001437402-26-000013-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerARDX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2014
SEC CIK0001437402
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2025

LineValue
Revenue$407.3M
Net income-$61.6M
Operating income-$41.0M
Net margin-15.1%
Operating margin-10.1%
Revenue growth+22.1%
Cash$68.0M
Total assets$501.6M
P/E (computed)Net income was not positive
P/S (computed)1.9×

Warning signs

Cash runway
35.8 months
$46.3M cash at September 30, 2026
Share count, 1 year
+3.5%
2025-10-23 to 2026-10-27 · +8.3% over 3 years
Going-concern doubt
No
10-Q filed November 3, 2026
Insider net buying, 12 months
-$2.4M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-03
Cash and burn$46.3M cash; operating cash flow -$3.9M a quarter.Report 2026-09-30
Shares outstanding251,372,553 (2026-10-27); 242,974,306 a year earlier; 232,137,709 three years earlier.Cover page 2026-10-27
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-12
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $1.9M, sold $4.3M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$127.7M-$737K$2.2M$46.3M$252.4M$468.2M10-Q 2026-11-03
Q2 2026
2026-06-30
$120.9M-$16.7M-$6.4M$97.2M$251.8M$450.9M10-Q 2026-08-06
Q1 2026
2026-03-31
$94.5M-$37.6M-$32.2M$31.2M$203.5M$427.7M10-Q 2026-04-30
Q4 2025
2025-12-31
$125.2M-$407K$21.0M$68.0M$202.8M$407.3M10-K 2026-02-19
Q3 2025
2025-09-30
$110.3M-$969K$365K$42.7M$202.1M$398.2M10-Q 2026-11-03
Q2 2025
2025-06-30
$97.7M-$19.1M-$25.3M$90.0M$201.4M$386.1M10-Q 2026-08-06
Q1 2025
2025-03-31
$74.1M-$41.1M-$38.5M$30.8M$151.3M$361.7M10-Q 2026-04-30
Q4 2024
2024-12-31
$116.1M$4.6M$9.8M$64.9M$150.9M$333.6M10-K 2026-02-19

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2025-11-03
Latest annual report10-K2026-02-19
Latest quarterly / interim10-Q2026-11-03
Latest current report8-K2026-11-03
Latest proxyDEFA14A2026-05-26

Source: SEC EDGAR submissions feed, 1,006 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+7.3%
1 month-1.0%
3 months-21.0%
Year to date-47.0%
1 year-47.0%
From 52-week high-61.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
LXRXLexicon Pharmaceuticals Inc.$1.75-2.23%$779.2M
ORICOric Pharmaceuticals Inc.$7.52-4.33%$779.5M
OBXObsidian Therapeutics Inc.$12.36-1.59%$763.5M
IVAInventiva S.A. American Depository Shares$3.32-9.78%$784.5M
COLLCollegium Pharmaceutical Inc.$25.43+0.43%$790.2M
IRWDIronwood Pharmaceuticals Inc.$4.85+0.41%$802.9M
SNDXSyndax Pharmaceuticals Inc.$9.13-3.39%$821.6M
RIGLRigel Pharmaceuticals Inc.$43.73-1.64%$823.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier